Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sanderson

Showing results (611-620 of 681) with videos related to

Pageof 69
Sort By:
Archives of Disease in Childhood|May 1, 1979
A year's experience of the rotavirus syndrome and its association with respiratory illnessH M Lewis, J V Parry, H A Davies, et al.
Molecular and Biochemical Parasitology|July 21, 2001
Substrate specificity of recombinant cysteine proteinase, CPB, of Leishmania mexicanaL C Alves, W A Judice, P M St Hilaire, et al.
Molecular Psychiatry|December 2, 2022
Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salienceMarios C Panayi, Thomas Boerner, Thomas Jahans-Price, et al.
Journal of Medicinal Chemistry|April 2, 2009
Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modelingPijus K Mandal, Donald Limbrick, David R Coleman, et al.
Parasite Immunology|July 1, 1997
Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoniL A Dent, G H Munro, K P Piper, et al.
Blood|April 1, 1988
Interleukin-5 is at 5q31 and is deleted in the 5q- syndromeG R Sutherland, E Baker, D F Callen, et al.
Proteomics|February 29, 2008
Determining the protein repertoire of Cryptosporidium parvum sporozoitesSanya J Sanderson, Dong Xia, Helena Prieto, et al.
International Urogynecology Journal|September 9, 2020
Sacral neuromodulation for symptomatic chronic urinary retention in females: do age and comorbidities make a difference?Rachel A High, William Winkelman, Joseph Panza, et al.
Clinical and Translational Science|January 27, 2021
First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-101, a dual CD28/ICOS antagonist, in healthy adult subjectsJing Yang, Jason D Lickliter, Jan L Hillson, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 1, 1989
Blood sulfhydryl level increases during hyperoxia: a marker of oxidant lung injuryC J Beehler, M L Simchuk, K M Toth, et al.
Pageof 69

Showing results (611-620 of 681) with videos related to

Sort By:
Pageof 69
Archives of Disease in Childhood|May 1, 1979
A year's experience of the rotavirus syndrome and its association with respiratory illnessH M Lewis, J V Parry, H A Davies, et al.
Molecular and Biochemical Parasitology|July 21, 2001
Substrate specificity of recombinant cysteine proteinase, CPB, of Leishmania mexicanaL C Alves, W A Judice, P M St Hilaire, et al.
Molecular Psychiatry|December 2, 2022
Glutamatergic dysfunction leads to a hyper-dopaminergic phenotype through deficits in short-term habituation: a mechanism for aberrant salienceMarios C Panayi, Thomas Boerner, Thomas Jahans-Price, et al.
Journal of Medicinal Chemistry|April 2, 2009
Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modelingPijus K Mandal, Donald Limbrick, David R Coleman, et al.
Parasite Immunology|July 1, 1997
Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoniL A Dent, G H Munro, K P Piper, et al.
Blood|April 1, 1988
Interleukin-5 is at 5q31 and is deleted in the 5q- syndromeG R Sutherland, E Baker, D F Callen, et al.
Proteomics|February 29, 2008
Determining the protein repertoire of Cryptosporidium parvum sporozoitesSanya J Sanderson, Dong Xia, Helena Prieto, et al.
International Urogynecology Journal|September 9, 2020
Sacral neuromodulation for symptomatic chronic urinary retention in females: do age and comorbidities make a difference?Rachel A High, William Winkelman, Joseph Panza, et al.
Clinical and Translational Science|January 27, 2021
First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-101, a dual CD28/ICOS antagonist, in healthy adult subjectsJing Yang, Jason D Lickliter, Jan L Hillson, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 1, 1989
Blood sulfhydryl level increases during hyperoxia: a marker of oxidant lung injuryC J Beehler, M L Simchuk, K M Toth, et al.
Pageof 69